|
Volumn 53, Issue 4, 2000, Pages 166-167
|
Highly active antiretroviral therapy for the treatment of Kaposi's sarcoma associated with primary human immunodeficiency virus type-1 infection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTIRETROVIRUS AGENT;
CD4 ANTIGEN;
CYTOTOXIC AGENT;
GAG PROTEIN;
GLYCOPROTEIN GP 120;
GLYCOPROTEIN GP 41;
INDINAVIR;
LAMIVUDINE;
PENICILLIN G;
PREDNISOLONE;
VIRUS RNA;
ZIDOVUDINE;
ADULT;
ARTICLE;
CASE REPORT;
CEREBROSPINAL FLUID;
CLINICAL FEATURE;
DISEASE ASSOCIATION;
FEVER;
HEADACHE;
HOMOSEXUALITY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
KAPOSI SARCOMA;
LYMPHOCYTE;
MALE;
MICTURITION DISORDER;
MUSCLE WEAKNESS;
NEUROSYPHILIS;
PLEOCYTOSIS;
POLYRADICULONEUROPATHY;
PRIMARY INFECTION;
SENSORY DYSFUNCTION;
SKIN BIOPSY;
THRUSH;
TREATMENT OUTCOME;
WESTERN BLOTTING;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
HIV INFECTIONS;
HIV-1;
HUMANS;
MALE;
MIDDLE AGED;
SARCOMA, KAPOSI;
|
EID: 0033652275
PISSN: 13446304
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (7)
|